Zentek Ltd. (ZTEK)
USD 0.98
(-4.85%)
USD 0.98
(-4.85%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.27 Million CAD | 73.94% |
| 2022 | -8.74 Million CAD | 64.22% |
| 2021 | -24.44 Million CAD | -809.64% |
| 2020 | -2.68 Million CAD | -233.42% |
| 2019 | -805.94 Thousand CAD | 34.02% |
| 2018 | -1.22 Million CAD | -1162.68% |
| 2017 | -96.73 Thousand CAD | 74.81% |
| 2016 | -383.96 Thousand CAD | -126.4% |
| 2015 | -169.59 Thousand CAD | -28.01% |
| 2014 | -132.48 Thousand CAD | 78.86% |
| 2013 | -626.63 Thousand CAD | 88.21% |
| 2012 | -5.31 Million CAD | -378.04% |
| 2011 | -1.11 Million CAD | -102.08% |
| 2010 | -550.37 Thousand CAD | 74.03% |
| 2009 | -2.11 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 151.3 Thousand CAD | 106.64% |
| 2023 Q4 | -2.27 Million CAD | 44.01% |
| 2023 Q3 | -4.06 Million CAD | 34.37% |
| 2023 FY | -2.27 Million CAD | 73.94% |
| 2023 Q1 | -20.62 Million CAD | -135.84% |
| 2023 Q2 | -6.2 Million CAD | 69.93% |
| 2022 Q2 | -16.07 Million CAD | 22.04% |
| 2022 Q3 | -12.48 Million CAD | 22.36% |
| 2022 FY | -8.74 Million CAD | 64.22% |
| 2022 Q4 | -8.74 Million CAD | 29.95% |
| 2022 Q1 | -20.62 Million CAD | 15.63% |
| 2021 Q1 | -4.1 Million CAD | -52.7% |
| 2021 Q3 | -2.76 Million CAD | 5.23% |
| 2021 Q4 | -24.44 Million CAD | -785.26% |
| 2021 Q2 | -2.91 Million CAD | 29.0% |
| 2021 FY | -24.44 Million CAD | -809.64% |
| 2020 Q3 | -1.69 Million CAD | 23.86% |
| 2020 Q1 | -1.86 Million CAD | -131.74% |
| 2020 FY | -2.68 Million CAD | -233.42% |
| 2020 Q4 | -2.68 Million CAD | -58.52% |
| 2020 Q2 | -2.22 Million CAD | -19.2% |
| 2019 Q3 | -1.45 Million CAD | -37.51% |
| 2019 Q4 | -805.94 Thousand CAD | 44.62% |
| 2019 FY | -805.94 Thousand CAD | 34.02% |
| 2019 Q1 | -528.67 Thousand CAD | 56.72% |
| 2019 Q2 | -1.05 Million CAD | -100.2% |
| 2018 Q2 | -376.54 Thousand CAD | 46.76% |
| 2018 Q1 | -707.21 Thousand CAD | -631.06% |
| 2018 FY | -1.22 Million CAD | -1162.68% |
| 2018 Q4 | -1.22 Million CAD | 56.23% |
| 2018 Q3 | -2.79 Million CAD | -641.12% |
| 2017 Q4 | -96.73 Thousand CAD | 78.96% |
| 2017 FY | -96.73 Thousand CAD | 74.81% |
| 2017 Q3 | -459.86 Thousand CAD | -118.34% |
| 2017 Q2 | -210.62 Thousand CAD | -453.34% |
| 2017 Q1 | -38.06 Thousand CAD | 90.09% |
| 2016 Q2 | -848.04 Thousand CAD | 70.89% |
| 2016 Q4 | -383.96 Thousand CAD | -20.7% |
| 2016 FY | -383.96 Thousand CAD | -126.4% |
| 2016 Q3 | -318.12 Thousand CAD | 62.49% |
| 2016 Q1 | -2.91 Million CAD | -1617.97% |
| 2015 Q4 | -169.59 Thousand CAD | 22.63% |
| 2015 FY | -169.59 Thousand CAD | -28.01% |
| 2015 Q3 | -219.19 Thousand CAD | -310.38% |
| 2015 Q2 | -53.41 Thousand CAD | 72.37% |
| 2015 Q1 | -193.32 Thousand CAD | -45.92% |
| 2014 Q1 | -572.91 Thousand CAD | 8.57% |
| 2014 Q2 | -30.85 Thousand CAD | 94.62% |
| 2014 Q4 | -132.48 Thousand CAD | 25.05% |
| 2014 FY | -132.48 Thousand CAD | 78.86% |
| 2014 Q3 | -176.76 Thousand CAD | -472.99% |
| 2013 Q4 | -626.63 Thousand CAD | 74.72% |
| 2013 Q1 | -9.6 Million CAD | -80.65% |
| 2013 FY | -626.63 Thousand CAD | 88.21% |
| 2013 Q2 | -6.63 Million CAD | 30.94% |
| 2013 Q3 | -2.47 Million CAD | 62.63% |
| 2012 Q4 | -5.31 Million CAD | -437.94% |
| 2012 Q3 | -988.32 Thousand CAD | -821.16% |
| 2012 Q1 | -38.02 Thousand CAD | 96.58% |
| 2012 FY | -5.31 Million CAD | -378.04% |
| 2012 Q2 | -107.29 Thousand CAD | -182.13% |
| 2011 Q3 | -1.71 Million CAD | 50.77% |
| 2011 Q4 | -1.11 Million CAD | 35.15% |
| 2011 FY | -1.11 Million CAD | -102.08% |
| 2011 Q1 | -1.47 Million CAD | -167.28% |
| 2011 Q2 | -3.48 Million CAD | -136.83% |
| 2010 Q3 | -9.55 Million CAD | 0.0% |
| 2010 FY | -550.37 Thousand CAD | 74.03% |
| 2010 Q4 | -550.37 Thousand CAD | 94.24% |
| 2009 Q4 | -2.11 Million CAD | 0.0% |
| 2009 FY | -2.11 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 188.293% |
| AngioDynamics, Inc. | -70.14 Million USD | 96.751% |
| AtriCure, Inc. | -9.81 Million USD | 76.784% |
| Avinger, Inc. | 10.12 Million USD | 122.518% |
| Azenta, Inc. | -618.47 Million USD | 99.632% |
| BioLife Solutions, Inc. | 7.25 Million USD | 131.419% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.093% |
| Daxor Corporation | 755.65 Thousand USD | 401.569% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -55.023% |
| Femasys Inc. | -15.01 Million USD | 84.823% |
| GlucoTrack, Inc. | -4.29 Million USD | 46.954% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 105.921% |
| Hologic, Inc. | 374.4 Million USD | 100.609% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.157% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.914% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 67.617% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 55.956% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 46.849% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 46.849% |
| Masimo Corporation | 804 Million USD | 100.283% |
| Microbot Medical Inc. | -2.28 Million USD | 0.313% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 76.252% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 100.754% |
| Nephros, Inc. | -2.47 Million USD | 7.777% |
| NovoCure Limited | 355.42 Million USD | 100.641% |
| NEXGEL, Inc. | 98 Thousand USD | 2425.344% |
| NEXGEL, Inc. | 98 Thousand USD | 2425.344% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 103.859% |
| OraSure Technologies, Inc. | -276.9 Million USD | 99.177% |
| Pro-Dex, Inc. | 10.91 Million USD | 120.876% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 93.53% |
| Predictive Oncology Inc. | -5.87 Million USD | 61.19% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 175.229% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.091% |
| Repligen Corporation | -39.51 Million USD | 94.234% |
| Sanara MedTech Inc. | 6.64 Million USD | 134.295% |
| STAAR Surgical Company | -147.2 Million USD | 98.452% |
| Sharps Technology, Inc. | -3.01 Million USD | 24.364% |
| Utah Medical Products, Inc. | -92.52 Million USD | 97.537% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.116% |
| Jin Medical International Ltd. | -2.81 Million USD | 19.09% |